Marker Therapeutics is trading 6.2% up at $1.25 today, extending a biotech-led rebound that began late last week.
- The move occurs despite a lack of fresh company-specific news or earnings reports being released today.
- Shares appear to be tracking ongoing strength across the broader biotech sector and a positive session for U.S. equities.
- The price action follows a significant sector-wide rally on Friday, as highlighted in recent market coverage.